Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Michael E. Ray"'
Autor:
William C. Jackson, MD, Felix Y. Feng, MD, Stephanie Daignault, PhD, Maha Hussain, MD, David Smith, MD, Kathleen Cooney, MD, Kenneth Pienta, MD, Shruti Jolly, MD, Brent Hollenbeck, MD, Karin B. Olson, PA-C, Howard M. Sandler, MD, Michael E. Ray, MD, PhD, Daniel A. Hamstra, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 1, Pp 59-66 (2016)
Purpose/Objective(s): We sought to assess the utility of docetaxel administered concurrently with salvage radiation therapy (SRT) following postprostatectomy biochemical failure (BF). Methods and materials: Men with postprostatectomy BF were accrued
Externí odkaz:
https://doaj.org/article/caf9011c751647a7ac6e69c0815d120f
Supplementary Data from Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature
Autor:
Daniel A. Hamstra, Michael E. Ray, Sonja Markwart, Yash R. Somnay, Aaron C. Spalding, James D. Murphy
Supplementary Data from Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d985c4687ec84f3dc5aae94df1452d5
https://doi.org/10.1158/1078-0432.22440364
https://doi.org/10.1158/1078-0432.22440364
Autor:
Jason A. Efstathiou, Per H. Halvorsen, Colleen A. Lawton, Bridget F. Koontz, Søren M. Bentzen, Caroline Patton, Michael E. Ray, Scott C. Morgan, Daniel W. Lin, D. Andrew Loblaw, Karen E. Hoffman, Michael Chang, Patrick Greany, Mark K. Buyyounouski, DA Barocas, C. Marc Leyrer, Howard M. Sandler
Publikováno v:
The Journal of urology. 201(3)
Purpose The aim of this guideline is to present recommendations regarding moderately hypofractionated (240-340 cGy per fraction) and ultrahypofractionated (500 cGy or more per fraction) radiation therapy for localized prostate cancer. Methods and Mat
Autor:
Michael E. Ray, David Smith, Shruti Jolly, Stephanie Daignault, William C. Jackson, Daniel A. Hamstra, Howard M. Sandler, Felix Y. Feng, Kathleen A. Cooney, Kenneth J. Pienta, Brent K. Hollenbeck, Maha Hussain, Karin B. Olson
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 1, Pp 59-66 (2016)
Advances in Radiation Oncology
Advances in Radiation Oncology
Purpose/Objective(s) We sought to assess the utility of docetaxel administered concurrently with salvage radiation therapy (SRT) following postprostatectomy biochemical failure (BF). Methods and materials Men with postprostatectomy BF were accrued on
Autor:
Daniel A. Barocas, Karen E. Hoffman, Scott C. Morgan, Bridget F. Koontz, Jason A. Efstathiou, Per H. Halvorsen, Michael Chang, Colleen A. Lawton, Søren M. Bentzen, Caroline Patton, D. Andrew Loblaw, Daniel W. Lin, Michael E. Ray, Patrick Greany, Mark K. Buyyounouski, Howard M. Sandler, C. Marc Leyrer
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
The aim of this guideline is to present recommendations regarding moderately hypofractionated (240-340 cGy per fraction) and ultrahypofractionated (500 cGy or more per fraction) radiation therapy for localized prostate cancer.The American Society for
Autor:
James D. Murphy, Aaron C. Spalding, Michael E. Ray, Yash R. Somnay, Daniel A. Hamstra, Sonja Markwart
Publikováno v:
Clinical Cancer Research. 15:589-596
Purpose: The PI3K/Akt/mTOR prosurvival pathway is frequently up-regulated in soft tissue sarcoma. Mammalian target of rapamycin (mTOR) inhibitors, such as rapamycin, have recently shown clinical benefit in soft tissue sarcoma, and mTOR inhibition has
Autor:
Evan T. Keller, Arul M. Chinnaiyan, Kathleen M. Woods Ignatoski, Sonja Markwart, Adaikkalam Vellaichamy, Kam C. Yeung, Michael E. Ray, Navdeep K. Grewal
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 72:153-160
Purpose External beam radiotherapy (RT) is often used in an attempt to cure localized prostate cancer (PCa), but it is only palliative against disseminated disease. Raf kinase inhibitory protein (RKIP) is a metastasis suppressor whose expression is r
Autor:
Charlie C. Pan, Daniel E. Soto, Michael E. Ray, R. Roberts, Scott Glaser, Matthew J. Schipper, Patrick W. McLaughlin, Howard M. Sandler
Publikováno v:
Urology. 71:313-317
Objectives The Radiation Therapy Oncology Group 9413 trial has shown an improvement in progression-free survival (PFS) with external beam radiotherapy that included the pelvic nodes. In clinical practice, two pelvic field size designs are in use. We
Autor:
James D. Murphy, Cornelius J. McGinn, Kent A. Griffith, Vernon K. Sondak, David R. Lucas, Laurence H. Baker, Michael E. Ray, Mary Feng
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 69:103-110
To determine the long-term outcomes after multimodality treatment of retroperitoneal, pelvic, and deep truncal sarcomas and to identify the factors associated with local control (LC), distant metastasis (DM), and overall survival (OS).A total of 85 p
Autor:
Edgar Ben-Josef, James D. Murphy, Saroja Adusumilli, Michael E. Ray, Kent A. Griffith, Mark M. Zalupski, Theodore S. Lawrence
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 68:801-808
Purpose: Full-dose gemcitabine and concurrent radiotherapy is a promising treatment approach in unresectable pancreatic cancer. This study was conducted to assess the pattern of failure and toxicity associated with the use of conformal treatment volu